In this Q&A, Dr Machado answers our questions about the impact that biologic disease-modifying antirheumatic drugs have in axial spondyloarthritis remission.
Johan K. Wallman, MD, PhD, from Lund University, answers our questions about his research on the prevalence of gut symptoms meeting criteria for irritable bowel syndrome (IBS) among patients with axial...
Dr Laura Plantinga discusses her and her colleagues recently published a study on the relevance of cognitive assessments among patients with systemic lupus erythematosus.
